Oligonucleotide-based drugs and therapeutics: preclinical and clinical considerations for development
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Hoboken, NJ
Wiley
2018
|
| Schlagworte: | |
| Beschreibung: | xxii, 553 Seiten Illustrationen, Diagramme |
| ISBN: | 9781118537336 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV045230095 | ||
| 003 | DE-604 | ||
| 005 | 20181030 | ||
| 007 | t | ||
| 008 | 181012s2018 a||| |||| 00||| eng d | ||
| 020 | |a 9781118537336 |9 978-1-118-53733-6 | ||
| 035 | |a (OCoLC)1048397099 | ||
| 035 | |a (DE-599)BVBBV045230095 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 | ||
| 050 | 0 | |a RM666.N87 | |
| 082 | 0 | |a 572.8/5 |2 23 | |
| 084 | |a VS 9400 |0 (DE-625)147728:253 |2 rvk | ||
| 245 | 1 | 0 | |a Oligonucleotide-based drugs and therapeutics |b preclinical and clinical considerations for development |c edited by Nicolay Ferrari and Rosanne Seguin |
| 264 | 1 | |a Hoboken, NJ |b Wiley |c 2018 | |
| 300 | |a xxii, 553 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Oligonucleotides |x Therapeutic use | |
| 650 | 4 | |a Antisense nucleic acids |x Therapeutic use | |
| 700 | 1 | |a Ferrari, Nicolay |4 edt | |
| 700 | 1 | |a Seguin, Rosanne |0 (DE-588)1168594324 |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, pdf |z 978-1-119-07029-0 |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe, epub |z 978-1-119-07030-6 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030618487 | ||
Datensatz im Suchindex
| _version_ | 1804178956361924609 |
|---|---|
| any_adam_object | |
| author2 | Ferrari, Nicolay Seguin, Rosanne |
| author2_role | edt edt |
| author2_variant | n f nf r s rs |
| author_GND | (DE-588)1168594324 |
| author_facet | Ferrari, Nicolay Seguin, Rosanne |
| building | Verbundindex |
| bvnumber | BV045230095 |
| callnumber-first | R - Medicine |
| callnumber-label | RM666 |
| callnumber-raw | RM666.N87 |
| callnumber-search | RM666.N87 |
| callnumber-sort | RM 3666 N87 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | VS 9400 |
| ctrlnum | (OCoLC)1048397099 (DE-599)BVBBV045230095 |
| dewey-full | 572.8/5 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 572 - Biochemistry |
| dewey-raw | 572.8/5 |
| dewey-search | 572.8/5 |
| dewey-sort | 3572.8 15 |
| dewey-tens | 570 - Biology |
| discipline | Chemie / Pharmazie Biologie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01227nam a2200349 c 4500</leader><controlfield tag="001">BV045230095</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20181030 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">181012s2018 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781118537336</subfield><subfield code="9">978-1-118-53733-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1048397099</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045230095</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.N87</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">572.8/5</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9400</subfield><subfield code="0">(DE-625)147728:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oligonucleotide-based drugs and therapeutics</subfield><subfield code="b">preclinical and clinical considerations for development</subfield><subfield code="c">edited by Nicolay Ferrari and Rosanne Seguin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, NJ</subfield><subfield code="b">Wiley</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxii, 553 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oligonucleotides</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antisense nucleic acids</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ferrari, Nicolay</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seguin, Rosanne</subfield><subfield code="0">(DE-588)1168594324</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, pdf</subfield><subfield code="z">978-1-119-07029-0</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe, epub</subfield><subfield code="z">978-1-119-07030-6</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030618487</subfield></datafield></record></collection> |
| id | DE-604.BV045230095 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T08:12:12Z |
| institution | BVB |
| isbn | 9781118537336 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030618487 |
| oclc_num | 1048397099 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM |
| owner_facet | DE-19 DE-BY-UBM |
| physical | xxii, 553 Seiten Illustrationen, Diagramme |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | Wiley |
| record_format | marc |
| spelling | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development edited by Nicolay Ferrari and Rosanne Seguin Hoboken, NJ Wiley 2018 xxii, 553 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Oligonucleotides Therapeutic use Antisense nucleic acids Therapeutic use Ferrari, Nicolay edt Seguin, Rosanne (DE-588)1168594324 edt Erscheint auch als Online-Ausgabe, pdf 978-1-119-07029-0 Erscheint auch als Online-Ausgabe, epub 978-1-119-07030-6 |
| spellingShingle | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development Oligonucleotides Therapeutic use Antisense nucleic acids Therapeutic use |
| title | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development |
| title_auth | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development |
| title_exact_search | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development |
| title_full | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development edited by Nicolay Ferrari and Rosanne Seguin |
| title_fullStr | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development edited by Nicolay Ferrari and Rosanne Seguin |
| title_full_unstemmed | Oligonucleotide-based drugs and therapeutics preclinical and clinical considerations for development edited by Nicolay Ferrari and Rosanne Seguin |
| title_short | Oligonucleotide-based drugs and therapeutics |
| title_sort | oligonucleotide based drugs and therapeutics preclinical and clinical considerations for development |
| title_sub | preclinical and clinical considerations for development |
| topic | Oligonucleotides Therapeutic use Antisense nucleic acids Therapeutic use |
| topic_facet | Oligonucleotides Therapeutic use Antisense nucleic acids Therapeutic use |
| work_keys_str_mv | AT ferrarinicolay oligonucleotidebaseddrugsandtherapeuticspreclinicalandclinicalconsiderationsfordevelopment AT seguinrosanne oligonucleotidebaseddrugsandtherapeuticspreclinicalandclinicalconsiderationsfordevelopment |